SEARCH

SEARCH BY CITATION

References

  • Ahuja SS, Reddick RL, Sato N, Montalbo E, Kostecki V, Zhao W, Dolan MJ, Melby PC & Ahuja SK (1999) Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J Immunol 163: 38903897.
  • Aichele P, Brduscha-Riem K, Oehen S, Odermatt B, Zinkernagel RM, Hengartner H & Pircher H (1997) Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 6: 519529.
  • Badovinac VK, Messingham AN, Jabbari A, Haring JS & Harty JT (2005) Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat Med 11: 748756.
  • Banchereau J & Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245252.
  • Bezbradica JS, Stanic AK, Matsuki N, Bour-Jordan HJ, Bluestone A, Thomas JW, Untmaz D, Kaer LV & Joyce S (2005) Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo. J Immunol 174: 46964705.
  • Burdin N, Brossay L & Kronenberg M (1999) Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol 29: 20142025.
  • Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT & Falo LD Jr (1996) Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 183: 283287.
  • Crowe NY, Uldrich AP, Kyparissoudis K, Hammond KJL, Hayakawa Y, Sidobre S, Keating R, Kronenberg M, Smyth MJ & Godfrey DI (2003) Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 171: 40204027.
  • Emoto M, Emoto Y, Buchwalow IB & Kaufmann SHE (1999) Induction of IFN-γ-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette-Guérin. Eur J Immunol 29: 650659.
  • Fujii S, Shimizu K, Kronenberg M & Steinman RM (2002) Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs. Nat Immunol 3: 867874.
  • Fujii S, Liu K, Smith C, Bonito AJ & Steinman RM (2004) The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199: 16071618.
  • Gelin BG & Broome CV (1989) Listeriosis. JAMA 261: 13131320.
  • Gonzalez-Aseguinolaza G, De Oliveira C, Tomaska M et al. (2000) α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci USA 97: 84618466.
  • Gumperz JE & Brenner MB (2001) CD1-specific T cells in microbial immunity. Curr Opin Immunol 13: 471478.
  • Harada M, Seino K, Wakao H, Sakata S, Ishizuka Y, Ito T, Kojo S, Nakayama T & Taniguchi M (2004) Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation. Int Immunol 16: 241247.
  • Harty JT & Bevan MJ (1992) CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med 175: 15311538.
  • Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Kaer LV, Saiki I & Okumura K (2001) Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity to anti-metastatic effect of α-galactosylceramide. Eur J Immunol 31: 17201727.
  • Hermans IF, Ritchie DS, Yang J, Roberts JM & Ronchese F (2000) CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J Immunol 164: 30953101.
  • Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L & Cerundolo V (2003) NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171: 51405147.
  • Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S & Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 16931702.
  • Ishikawa H, Hisaeda H, Taniguchi M et al. (2000) CD4+ Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol 12: 12671274.
  • Ishikawa A, Motohashi S, Ishikawa E, Fuchida H, Higashino K, Otsuji M, Iizasa T, Nakayhama T, Taniguchi M & Fujisawa T (2005) A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 11: 19101917.
  • Kakimi K, Guidotti LG, Koezuka Y & Chisari FV (2000) Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192: 921930.
  • Kikuchi T, Worgall S, Singh R, Moore MA & Crystal RG (2000) Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells. Nat Med 6: 11541159.
  • Kitamura H, Iwakabe K, Yahata T et al. (1999) The natural killer (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 189: 11211127.
  • Kronenberg M (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 23: 877900.
  • Kronenberg M & Gapin L (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2: 557568.
  • Lefrançois L & Masopust D (2002) T cell immunity in lymphoid and non-lymphoid tissues. Curr Opin Immunol 14: 503508.
  • Manickan E, Kanangat S, Rouse RJ, Yu Z & Rouse BT (1997) Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukoc Biol 61: 125132.
  • Mayordomo JI, Zorina T, Stokus WJ et al. (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat Med 1: 12971302.
  • Nakamura Y, Suda T, Nagata T, Aoshi T, Uchijima M, Yoshida A, Chida K, Koide Y & Nakamura H (2003) Induction of protective immunity to Listeria monocytogenes with dendritic cells retrovirally transduced with a cytotoxic T lymphocyte epitope minigene. Infect Immun 71: 17481754.
  • Nishimura T, Kitamura H, Iwakabe K et al. (2000) The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol 12: 987994.
  • Pamer EG (2004) Immune responses to Listeria monocytogenes. Nat Rev Immunol 4: 812823.
  • Ranieri E, Herr W, Gambotto A, Olson W, Rowe D, Robbins PD, Salvucci Kierstead L, Watkins SC, Gesualdo L & Storkus WJ (1999) Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination. J Virol 73: 1041610425.
  • Ranson T, Bregenholt S, Lehuen A, Gaillot O, Leite-de-Moraes MC, Herbelin A, Berche P & Di Santo JP (2005) Invariant Vα14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection. J Immunol 175: 11371144.
  • Roberts AD, Ely KH & Woodland DL (2005) Differential contributions of central and effector memory T cells to recall responses. J Exp Med 202: 123133.
  • Ronchese F & Hermans IF (2001) Killing of dendritic cells: a life cut short or a purposeful death? J Exp Med 194: F23F26.
  • Seder RA & Hill AV (2000) Vaccines against intracellular infections requiring cellular immunity. Nature 406: 793798.
  • Shaw JH, Grund VR, Durling L & Caldwell HD (2001) Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by Chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy. Infect Immun 69: 46674672.
  • Silk JD, Hermans IF, Gileadi U et al. (2004) Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest 114: 18001811.
  • Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H & Godfrey DI (2002) Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99: 12591266.
  • Uchijima M, Yoshida A, Nagata T & Koide Y (1998) Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J Immunol 161: 55945599.
  • Vaccari M, Trindade CJ, Venzon D & Zanetti M (2005) Vaccine-induced CD8+ central memory T cells in protection from simian AIDS. J Immunol 175: 35023507.
  • Wherry EJ, Teichgräber V, Becker TC, Masopust D, Kaech SM, Antia R, Von Andrian UH & Ahmed R (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225234.
  • Whitmire JK, Tan JT & Whitton JL (2005) Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infection. J Exp Med 201: 10531059.
  • Wilson MT, Johansson C, Olivares-Villagómez D, Singh AK, Stanic AK, Wang C-R, Joyce S, Wick MJ & Kaer LV (2003) The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci USA 100: 1091310918.
  • Woodland DL & Blackman MA (2005) Vaccine development: baring the ‘dirty little secret’. Nat Med 11: 715716.
  • Zaph C, Uzonna J, Beverley SM & Scott P (2004) Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med 10: 11041110.